title: Simultaneous Determination and Pharmacokinetic Study of Losartan, Losartan Carboxylic Acid, Ramipril, Ramiprilat, and Hydrochlorothiazide in Rat Plasma by a Liquid Chromatography/Tandem Mass Spectrometry Method.
abstract: The monitoring of the plasmatic concentrations of cardiovascular drugs is crucial for understanding their pharmacokinetics and pharmacodynamics. A simple, sensitive, specific, and high-throughput liquid chromatography/tandem mass spectrometry (LC-MS/MS) method was developed and validated for the simultaneous estimation and pharmacokinetic study of losartan (LOS), losartan carboxylic acid (LCA), ramipril (RAM), ramiprilate (RPT), and hydrochlorothiazide (HCZ) in rat plasma using irbesartan (IBS) and metolazone (MET) as internal standards (ISs). After solid phase extraction (SPE), analytes and ISs were separated on an Agilent Poroshell 120, EC-C18 (50 mm × 4.6 mm, i.d., 2.7 μm) column with a mobile phase consisting of methanol/water (85:15, v/v) containing 5 mmol/L ammonium formate and 0.1% formic acid at a flow rate of 0.4 mL/min. The precursor → product ion transitions for the analytes and ISs were monitored on a triple quadrupole mass spectrometer, operating in the multiple reaction monitoring (MRM) mode and switching the electrospray ionization (ESI) mode during chromatography from positive (to detect LOS, LCA, RAM, RPT, and IBS) to negative (to detect HCZ and MET). The method was validated as per the FDA guidelines and it exhibited sufficient specificity, accuracy, and precision. The method was found to be linear in the range of 3-3000 ng/mL for LOS and LCA, 0.1-200 ng/mL for RAM and RPT, and 1-1500 ng/mL for HCZ. The described method was successfully applied to the preclinical pharmacokinetic study of analytes after oral administration of a mixture of LOS (10 mg/kg), RAM (1 mg/kg), and HCZ (2.5 mg/kg) in rats.
authors.affiliation: Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, India.
authors.forename: Ramkumar
authors.initials: R
authors.lastname: Dubey
authors.affiliation: Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, India.
authors.forename: Manik
authors.initials: M
authors.lastname: Ghosh
keywords: LC-MS/MS; Pharmacokinetic; Plasma; Simultaneous estimation; Validation
references.citation: J Chromatogr B Biomed Sci Appl. 1999 Nov 12;734(2):325-30
references.pmid: 10595730
references.citation: J Biopharm Stat. 2001 Feb-May;11(1-2):75-9
references.pmid: 11459444
references.citation: Clin Pharmacol Ther. 2002 Jan;71(1):89-98
references.pmid: 11823761
references.citation: J Hum Hypertens. 2002 Aug;16 Suppl 3:S17-25
references.pmid: 12140724
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Nov 5;779(2):297-306
references.pmid: 12361743
references.citation: J Pharm Biomed Anal. 2003 Sep 15;33(1):73-84
references.pmid: 12946533
references.citation: Anal Chem. 2003 Jul 1;75(13):3019-30
references.pmid: 12964746
references.citation: Hypertension. 2003 Dec;42(6):1206-52
references.pmid: 14656957
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Jul 5;806(2):199-203
references.pmid: 15171930
references.citation: J Pharm Biomed Anal. 2006 Feb 13;40(2):478-83
references.pmid: 16181761
references.citation: Int J Clin Pharmacol Ther. 2006 Feb;44(2):93-8
references.pmid: 16502769
references.citation: Int J Clin Pract. 2006 Apr;60(4):391-8
references.pmid: 16620350
references.citation: Eur J Pharm Biopharm. 2007 May;66(2):227-43
references.pmid: 17127045
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Oct 15;858(1-2):13-21
references.pmid: 17825632
references.citation: Rapid Commun Mass Spectrom. 2007;21(21):3427-34
references.pmid: 17902196
references.citation: J Vet Pharmacol Ther. 2008 Aug;31(4):349-58
references.pmid: 18638296
references.citation: Anal Bioanal Chem. 2008 Oct;392(4):681-98
references.pmid: 18704378
references.citation: J Pharm Biomed Anal. 2009 Apr 5;49(3):862-7
references.pmid: 19217738
references.citation: Hypertension. 1991 Nov;18(5 Suppl):III136-42
references.pmid: 1937677
references.citation: J Sep Sci. 2009 Oct;32(20):3388-94
references.pmid: 19750501
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Nov 1;877(29):3673-80
references.pmid: 19782651
references.citation: Biomed Chromatogr. 2011 Apr;25(4):439-49
references.pmid: 20629042
references.citation: Biomed Chromatogr. 2011 Jun;25(6):664-73
references.pmid: 20812207
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Oct 15;878(28):2685-92
references.pmid: 20846917
references.citation: Talanta. 2011 Jan 15;83(3):709-16
references.pmid: 21147310
references.citation: J Vet Pharmacol Ther. 2011 Oct;34(5):518-20
references.pmid: 21906084
references.citation: J Pharmacol Exp Ther. 1990 Oct;255(1):211-7
references.pmid: 2213556
references.citation: Bioanalysis. 2012 Jun;4(10):1195-204
references.pmid: 22651563
references.citation: Vasc Health Risk Manag. 2012;8:371-80
references.pmid: 22745561
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Jul 15;901:98-106
references.pmid: 22762913
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Aug 1;902:47-54
references.pmid: 22770781
references.citation: Curr Opin Nephrol Hypertens. 2012 Sep;21(5):486-91
references.pmid: 22871676
references.citation: Clin Ther. 2013 Mar;35(3):226-35
references.pmid: 23497760
references.citation: Hypertension. 2013 Jun;61(6):1239-45
references.pmid: 23608658
references.citation: J Pharm Biomed Anal. 2013 Jul-Aug;81-82:99-107
references.pmid: 23648556
references.citation: Biomed Chromatogr. 2013 Sep;27(9):1219-24
references.pmid: 23722257
references.citation: Pharm Methods. 2012 Jan;3(1):18-25
references.pmid: 23781473
references.citation: J Hypertens. 2013 Jul;31(7):1281-357
references.pmid: 23817082
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Nov 1;970:53-9
references.pmid: 25240204
references.citation: J Pharm Anal. 2014 Dec;4(6):399-406
references.pmid: 29403906
references.citation: Drugs. 1985 Feb;29(2):162-88
references.pmid: 3884320
references.citation: Hypertension. 1995 May;25(5):928-34
references.pmid: 7737729
references.citation: Br Heart J. 1994 Feb;71(2):146-50
references.pmid: 8130022
references.citation: J Hypertens. 1993 Feb;11(2):155-62
references.pmid: 8385175
references.citation: J Biopharm Stat. 1998 May;8(2):317-28
references.pmid: 9598425